China ATTUNE® Study

Osteoarthritis Clinical Trial

Official title:

A Prospective Single-arm Multicenter Study to Evaluate Clinical Performance of Cemented ATTUNE® Knee System in Primary Total Knee Arthroplasty

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03542045
• Other study ID #: DPS-201701
• Status: Completed
• Start date: April 12, 2018
• Est. completion date: November 19, 2021

Study information

• Verified date: April 2022
• Source: DePuy Orthopaedics
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The study was designed as prospective, single-arm, multi-center which was intended to broadly capture all patients as the technology is adopted.

Description:

The primary objective is to evaluate the implant survivorship of ATTUNE primary, cemented Knee system in Chinese patients using Kaplan Meier Survivorship at 2 yrs. The subject population is male and female subjects who are candidates for primary, total knee arthroplasty between 18 and 80 years of age, inclusive, willing to consent with indications consistent with the Instructions for Use. A total of 120 subjects will be enrolled in this study.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 120
• Est. completion date: November 19, 2021
• Est. primary completion date: November 19, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

1. Subjects with Subjects with Osteoarthritis (OA), post-trauma arthritis.

2. Subject is male or female and between the ages of 18 and 80 years old, inclusive.

3. Subject requires a primary total knee replacement with or without un-resurfaced patella and is considered by the Investigator to be suitable for the specific knee prosthesis identified in the protocol.

4. Subject requires unilateral knee replacement or the first knee with ATTUNE system during the study will be enrolled for bilateral knee replacement.

5. Subject, or with the aid of a family member, is able to understand the Informed Consent Document and patient questionnaires.

6. Subject, with the aid of a family member as needed, has given voluntary, written informed consent to participate in this clinical investigation and has authorized the transfer of his/her information to the Sponsor.

7. Subject, in the opinion of the Investigator, is able to understand this clinical investigation and is willing and able to perform all study procedures and follow-up visits and co-operate with investigational procedures.

Exclusion Criteria:

1. The Subject has, in the opinion of the Investigator, an existing condition that would compromise their participation and follow-up in this study, e.g. living in distant areas or having difficulty to return to the site, incooperative to surgeons' medical instructions and suggestions.

2. The Subject is a woman who is pregnant or lactating.

3. The Subject, in the opinion of the Investigator, is a drug or alcohol abuser (in the last 5 years) or has a psychological disorder that could affect follow-up care or treatment outcomes.

4. The Subject has participated in a clinical investigation with an investigational product in the last 3 months that could impact/affect the outcome of the current procedure and follow-ups judged by the investigator.

5. The Subject has previous prosthetic knee replacement (any type including unicompartmental, total knee arthroplasty, patellofemoral arthroplasty or ipsilateral Upper Tibial Osteotomy (UTO)/ High Tibial Osteotomy (HTO)) of the affected knee or a previous patellectomy.

6. Subject has significant neurological or musculoskeletal disorders or disease that may adversely affect gait or weight bearing (e.g. muscular dystrophy, multiple sclerosis, cerebral infarction, hemiplegia, Charcot disease, avascular necrosis).

7. The Subject requires a device not specified in the protocol or the surgeon determines that the ATTUNE Knee System is not a suitable treatment.

Related Conditions & MeSH terms

• Osteoarthritis
• Post-traumatic Arthritis

Intervention

Device:
• Cemented ATTUNE® Knee System
This product is for total knee arthroplasty. Four implant configurations are permitted: Cruciate Retaining Fixed Bearing (CR FB), Cruciate Retaining Rotating Platform (CR RP), Posterior Stabilizing Fixed Bearing (PS FB) and Posterior Stabilizing Rotating Platform (PS RP)

Locations

Country	Name	City	State
China	Yantaishan Hospital	Yantai	Shangdong

Sponsors (1)

Lead Sponsor	Collaborator
DePuy Orthopaedics

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Knee Society Score (KSS) 2011-surgeon portion at post-operative 6 weeks, 6 months and 1 year compared to pre-op baseline.	Questionnaire.	Pre-operative baseline, post-operative 6 weeks, 6 months, and 1 year.
Other	Knee injury and Osteoarthritis Outcome Score (KOOS) at postoperative 6 weeks, 6 months, 1 year compared to pre-op baseline.	Questionnaire.	Pre-operative baseline, post-operative 6 weeks, 6 months and 1 year.
Other	Euro Quality of life five Dimensions questionnaire five level (EQ5D-5L) at postoperative 6 weeks, 6 months, 1 year compared to pre-op baseline.	Questionnaire.	Pre-operative baseline, post-operative 6 weeks, 6 months and 1 year.
Other	Knee society score (KSS) 2011-patient portion at post-operative 6 weeks, 6 months, 1 year compared to pre-op baseline.	Questionnaire.	Pre-operative baseline, post-operative 6 weeks, 6 months and 1 year.
Other	Radiographic evaluation.	Radiographic evaluation at immediate post operation and 6 weeks, 1 year visit.	Immediate post operation, post-operative 6 weeks and 1 year.
Primary	Implant survivorship.	To evaluate the implant survivorship of ATTUNE primary, cemented Knee system in Chinese patients using Kaplan Meier Survivorship at 2 yrs.	postoperatively 2 years.
Secondary	Knee society score (KSS) 2011-surgeon portion at post-operative 2 years compared to pre-op baseline.	Questionnaire.	pre-operative and post-operative 2 years.
Secondary	Knee injury and Osteoarthritis Outcome Score (KOOS) at postoperative 2 years compared to pre-op baseline.	Questionnaire.	Pre-operative baseline and post-operative 2 years.
Secondary	Euro Quality of life five Dimensions questionnaire five level (EQ5D-5L) at postoperative 2 years compared to pre-op baseline.	Questionnaire.	Pre-operative and post-operative 2 years.
Secondary	Knee society score (KSS) 2011-patient portion at post-operative 2 years compared to pre-op baseline.	Questionnaire.	Pre-operative baseline and post-operative 2 years.
Secondary	Adverse events and serious adverse events.	Type and frequency of adverse events and serious adverse events.	Up to post-operative 2 years.
Secondary	Implant survivorship.	Kaplan Meier Survivorship at 1 year.	Post-operative 1 year.
Secondary	Health economy.	Patient total charges in hospital.	Post-operative 2 years.
Secondary	Length of hospital stay.	Hospitalization duration for primary surgery.	Through hospitalization for primary surgery, an average of 2 weeks.
Secondary	Destination status.	Home or rehabilitation department/secondary care facility/nursing facility.	At discharge of primary surgery, an average of post-operative 7 days.